Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003
Ventilation heterogeneity in children with severe asthma Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma Year: 2017
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017
What are the differences between moderate and severe COPD exacerbation groups? Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Relationship between benralizumab exposure and asthma exacerbation rate for patients with severe asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Impact of the eosinophil variability on severe exacerbations in an asthmatic population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005
The correlation between asthma severity and rhinitis severity Source: Eur Respir J 2002; 20: Suppl. 38, 45s Year: 2002
Clinical phenotypic differences between COPD and asthma in elderly patients Source: Eur Respir J 2004; 24: Suppl. 48, 60s Year: 2004
Incidence of COPD and asthma overlap Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009
Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002
The longitudinal association of daily physical activity and symptoms of exacerbations in COPD patients Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017
Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Risk factors for moderate exacerbations in childhood asthma Source: Eur Respir J 2004; 24: Suppl. 48, 163s Year: 2004
COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
The ERS/EAACI statement on severe exacerbations of asthma, and how to deal with non-allergic severe asthma Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma Year: 2019
Physical status and dependence levels in patients with COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014